93 related articles for article (PubMed ID: 2783649)
1. Kinetic analysis of the elimination process of human epidermal growth factor (hEGF) in rats.
Kim DC; Sugiyama Y; Fuwa T; Sakamoto S; Iga T; Hanano M
Biochem Pharmacol; 1989 Jan; 38(2):241-9. PubMed ID: 2783649
[TBL] [Abstract][Full Text] [Related]
2. Kinetic analysis of in vivo receptor-dependent binding of human epidermal growth factor by rat tissues.
Kim DC; Sugiyama Y; Satoh H; Fuwa T; Iga T; Hanano M
J Pharm Sci; 1988 Mar; 77(3):200-7. PubMed ID: 3259628
[TBL] [Abstract][Full Text] [Related]
3. Kinetic study of the hepatobiliary transport of a new prostaglandin receptor agonist.
Imawaka H; Sugiyama Y
J Pharmacol Exp Ther; 1998 Mar; 284(3):949-57. PubMed ID: 9495854
[TBL] [Abstract][Full Text] [Related]
4. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
5. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
Reilly RM; Chen P; Wang J; Scollard D; Cameron R; Vallis KA
J Nucl Med; 2006 Jun; 47(6):1023-31. PubMed ID: 16741313
[TBL] [Abstract][Full Text] [Related]
6. Renal clearance of domoic acid in the rat.
Suzuki CA; Hierlihy SL
Food Chem Toxicol; 1993 Oct; 31(10):701-6. PubMed ID: 8225127
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of proinsulin, insulin, and C-peptide in the rat.
Katz AI; Rubenstein AH
J Clin Invest; 1973 May; 52(5):1113-21. PubMed ID: 4700486
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent plasma clearance of human epidermal growth factor in rats.
Murakami T; Misaki M; Masuda S; Higashi Y; Fuwa T; Yata N
J Pharm Sci; 1994 Oct; 83(10):1400-3. PubMed ID: 7884658
[TBL] [Abstract][Full Text] [Related]
9. [Study of disposition of adriamycin and mitomycin C in liver by determination of plasma concentrations in hepatic vein and artery during intravenous constant infusion in rats].
Fuse E; Takai K; Kobayashi H; Kobayashi S
Gan To Kagaku Ryoho; 1997 Jun; 24(8):975-9. PubMed ID: 9212807
[TBL] [Abstract][Full Text] [Related]
10. The fate and uptake of murine epidermal growth factor in the sheep.
Tyson LM; Browne CA; Jenkin G; Thorburn GD
J Endocrinol; 1989 Oct; 123(1):121-30. PubMed ID: 2809484
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
[TBL] [Abstract][Full Text] [Related]
12. Plasma clearance rates and renal clearance of 3H-labeled cyclic AMP and 3H-labeled cyclic GMP in the dog.
Blonde L; Wehmann RE; Steiner AL
J Clin Invest; 1974 Jan; 53(1):163-72. PubMed ID: 4357610
[TBL] [Abstract][Full Text] [Related]
13. Efficient extraction by the liver governs overall elimination of hepatocyte growth factor in rats.
Kato M; Kato Y; Nakamura T; Sugiyama Y
J Pharmacol Exp Ther; 1999 Jul; 290(1):373-9. PubMed ID: 10381802
[TBL] [Abstract][Full Text] [Related]
14. Fate of circulating oxalate in rats.
Sugimoto T; Osswald H; Yamamoto K; Kanazawa T; Iimori H; Funae Y; Kamikawa S; Kishimoto T
Eur Urol; 1993; 23(4):485-9. PubMed ID: 8335055
[TBL] [Abstract][Full Text] [Related]
15. Metabolism of pure human erythropoietin in the rat.
Emmanouel DS; Goldwasser E; Katz AI
Am J Physiol; 1984 Jul; 247(1 Pt 2):F168-76. PubMed ID: 6742201
[TBL] [Abstract][Full Text] [Related]
16. Influence of formulation variables on the biodistribution of multifunctional block copolymer micelles.
Fonge H; Huang H; Scollard D; Reilly RM; Allen C
J Control Release; 2012 Feb; 157(3):366-74. PubMed ID: 21982897
[TBL] [Abstract][Full Text] [Related]
17. [Uptake and distribution of epidermal growth factor in certain organs of the dog].
Sendur R; Mazur G; Pawlik WW; Konturek SJ
Folia Med Cracov; 1991; 32(3-4):185-95. PubMed ID: 1845316
[TBL] [Abstract][Full Text] [Related]
18. Application of HPLC in disposition study of A14-125I-labeled insulin in mice.
Sato H; Tsuji A; Hirai K; Kang YS
Diabetes; 1990 May; 39(5):563-9. PubMed ID: 2185107
[TBL] [Abstract][Full Text] [Related]
19. An evaluation method for nonlinear local disposition in rat liver and kidney.
Kato T; Yamaoka K; Takakura Y
Drug Metab Dispos; 2004 Feb; 32(2):230-4. PubMed ID: 14744945
[TBL] [Abstract][Full Text] [Related]
20. Effect of absorption promoters on subcutaneous absorption of human epidermal growth factor in rats.
Murakami T; Misaki M; Kojima Y; Yamada M; Yuki M; Higashi Y; Amagase H; Fuwa T; Yata N
J Pharm Sci; 1993 Mar; 82(3):236-9. PubMed ID: 7680713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
